Journal of Brain and Neurology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Opinion Article - Journal of Brain and Neurology (2024) Volume 7, Issue 1

Understanding Neurodegeneration: Mechanisms and pathways of neuronal decline

Andres Cortes*

Department of Clinical Neurosciences, University of Neurological Institute, USA

*Corresponding Author:
Andres Cortes
Department of Clinical Neurosciences
University of Neurological Institute, USA
E-mail: aalc84@gmail.com

Received: 02-Feb-2024, Manuscript No. AAJBN-24-171774; Editor assigned: 03-Feb-2024, Pre QC No. AAJBN-24-171774 (PQ); Reviewed: 16-Feb-2024, QC No. AAJBN-24-171774; Revised: 20-Feb-2024, Manuscript No. AAJBN-24-171774 (R); Published: 27-Feb-2024, DOI: 10.35841/aajbn-7.1.171

Citation: Cortes A. Understanding Neurodegeneration: Mechanisms and pathways of neuronal decline. J Brain Neurol. 2024;7(1):171

Visit for more related articles at Journal of Brain and Neurology

Introduction

Neurodegeneration represents a complex and progressive process characterized by the gradual loss of structure and function of neurons, eventually leading to their death. This phenomenon underlies many debilitating neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). Despite extensive research, the precise mechanisms that drive neurodegenerative processes remain elusive, posing a significant challenge to effective prevention and treatment. The study of neurodegeneration combines molecular biology, genetics, and neuroscience to understand how neurons deteriorate and how these mechanisms might be reversed or slowed. [1].

One of the central features of neurodegeneration is the accumulation of misfolded proteins within neural cells. In Alzheimer’s disease, amyloid-beta plaques and tau tangles disrupt synaptic communication and cellular transport systems, while in Parkinson’s disease, α-synuclein aggregates form Lewy bodies that impair neuronal function. These abnormal protein accumulations lead to oxidative stress, mitochondrial dysfunction, and cellular toxicity. The inability of neurons to effectively clear these protein aggregates is often associated with dysfunction in autophagy and the ubiquitin-proteasome system, mechanisms responsible for cellular maintenance and waste removal. [2].

Mitochondrial dysfunction is another hallmark of neurodegenerative diseases. Neurons are highly dependent on energy, and even slight impairments in mitochondrial activity can have profound consequences. Damaged mitochondria produce excessive reactive oxygen species (ROS), which can oxidize proteins, lipids, and DNA, leading to further neuronal injury. This oxidative stress triggers a self-reinforcing cycle of mitochondrial damage and cellular death, exacerbating disease progression. Research into mitochondrial health has therefore become a major focus of neuroprotective strategies aimed at maintaining neuronal viability. [3].

Neuroinflammation also plays a critical role in the progression of neurodegeneration. Microglia, the immune cells of the central nervous system, are responsible for maintaining neural homeostasis and responding to injury. However, chronic activation of microglia can result in the release of pro-inflammatory cytokines, which can damage neurons and synapses. While acute inflammation serves a protective role, persistent inflammatory signaling contributes to neuronal loss and disease advancement. Balancing the beneficial and harmful effects of neuroinflammation remains an important therapeutic goal. [4].

Genetic factors contribute significantly to neurodegenerative disorders, with several mutations identified that increase susceptibility. For example, mutations in the APP, PSEN1, and PSEN2 genes are linked to familial Alzheimer’s disease, while mutations in the SNCA gene are associated with hereditary Parkinson’s disease. Genetic research has also revealed the involvement of pathways related to lysosomal function, synaptic maintenance, and RNA metabolism. Understanding these genetic underpinnings provides valuable insight into disease mechanisms and offers potential targets for gene-based therapy and precision medicine. [5].

Conclusion

Neurodegeneration remains one of the most challenging areas in biomedical research due to its complex and multifactorial nature. Understanding the interplay between genetic predisposition, environmental triggers, and cellular mechanisms is crucial for developing effective treatments. While no definitive cure currently exists for most neurodegenerative diseases, advances in molecular neuroscience, gene editing, and neuroprotective therapies offer hope for future breakthroughs. Continued interdisciplinary research will be essential to unravel the mechanisms of neuronal decline and pave the way for innovative strategies to preserve cognitive and motor function throughout aging.

References

  1. Cebral JR, Castro MA, Soto O, et al. Blood-flow in the Circle of Willis from magnetic resonance data. J Eng Math. 2003;47(4):369-86.

    2. Indexed at, Google Scholar, Cross Ref

  2. Atabek HB. Wave propagation through a viscous fluid contained in a tethered, initially stressed, orthotropic elastic tube. J Biophys. 1968;8:626-49.

    3. Indexed at, Google Scholar, Cross Ref

  3. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.

    4. Indexed at, Google Scholar, Cross Ref

  4. Kim BJ, Kang GH, Ahn SH, et al. Magnetic Resonance Imaging in Acute Ischemic Stroke Treatment. J Stroke. 2014;16(3):131-45.

    5. Indexed at, Google Scholar, Cross Ref

  5. Kumamaru KK, Hoppel BE, Mather RT, et al. CT Angiography: Current Technology and Clinical Use. Radiol Clin North Am. 2010;48(20):213-35.

    6. Indexed at, Google Scholar, Cross Ref

Get the App